Hormonal
Pre-pregnancy use of GLP-1 receptor agonists (e.g., liraglutide) or GLP-1/GIP co-agonists (e.g., tirzepatide) is a promising pharmacotherapeutic strategy for pre-pregnancy weight loss in obese women, potentially mitigating the intergenerational risk of MAFLD in offspring, provided sufficient wash-out periods are observed.
If lifestyle changes aren't enough to help you reach a healthy weight before pregnancy, talk to your doctor about GLP-1 medications. They are effective for weight loss and may improve your future child's liver health. Crucially, you must stop these medications well before trying to conceive to ensure they are out of your system.
GLP-1 receptor agonists and GLP-1/GIP co-agonists are promising weight loss agents that could be valuable for pre-conception weight reduction to improve fertility and pregnancy outcomes and extend these benefits to the health of their offspring.
Why this rating
Supported by clinical trials for weight loss (LEAN, SURMOUNT-1) and animal models for fertility, but direct evidence for offspring MAFLD prevention via these drugs is explicitly stated as 'largely unknown'.
Source
Maternal Weight Management to Prevent the Developmental Programming of MAFLD in Offspring of Obese Mothers
Amanda R. Purcell et al. · Nutrients · 2023
DOI 10.3390/nu15092155
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →